Hofseth Biocare (Norway) Today
| HBC Stock | NOK 1.31 0.01 0.76% |
Performance0 of 100
| Odds Of DistressLess than 11
|
Hofseth Biocare is selling for 1.31 as of the 29th of November 2024. This is a 0.76% down since the beginning of the trading day. The stock's lowest day price was 1.24. Hofseth Biocare has less than a 11 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Hofseth Biocare ASA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of January 2023 and ending today, the 29th of November 2024. Click here to learn more.
Hofseth BioCare ASA, a biotech company, offers value added biomarine ingredients and finished products for human consumption and pet in Norway. The company was founded in 2000 and is headquartered in lesund, Norway. HOFSETH BIOCARE operates under Pharmaceuticals And Biosciences classification in Norway and is traded on Oslo Stock Exchange. The company has 395.08 M outstanding shares. More on Hofseth Biocare ASA
Moving together with Hofseth Stock
Moving against Hofseth Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Hofseth Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Hofseth Biocare's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Hofseth Biocare or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Hofseth Biocare ASA (HBC) is traded on Oslo Stock Exchange in Norway and employs 9 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hofseth Biocare's market, we take the total number of its shares issued and multiply it by Hofseth Biocare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Hofseth Biocare ASA operates under Healthcare sector and is part of Biotechnology industry. The entity has 395.08 M outstanding shares.
Hofseth Biocare ASA has accumulated about 36.52 M in cash with (61.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12.
Check Hofseth Biocare Probability Of Bankruptcy
Ownership AllocationHofseth Biocare ASA has a total of 395.08 Million outstanding shares. Hofseth Biocare secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Hofseth Ownership Details
Hofseth Biocare ASA Risk Profiles
Although Hofseth Biocare's alpha and beta are two of the key measurements used to evaluate Hofseth Biocare's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.62 | |||
| Standard Deviation | 4.03 | |||
| Variance | 16.23 | |||
| Risk Adjusted Performance | (0.11) |
Hofseth Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Hofseth Biocare without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Hofseth Biocare Corporate Management
Elected by the shareholders, the Hofseth Biocare's board of directors comprises two types of representatives: Hofseth Biocare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hofseth. The board's role is to monitor Hofseth Biocare's management team and ensure that shareholders' interests are well served. Hofseth Biocare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hofseth Biocare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Angelika Florvaag | Chief Officer | Profile | |
| Olav Flaten | Exec | Profile | |
| Tanja Schaffer | EVP GmbH | Profile | |
| Jon Odegard | Chief Officer | Profile | |
| Matt Mixter | Managing America | Profile | |
| Bomi Framroze | Chief Officer | Profile | |
| James Berger | Chief Officer | Profile |
Other Information on Investing in Hofseth Stock
Hofseth Biocare financial ratios help investors to determine whether Hofseth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hofseth with respect to the benefits of owning Hofseth Biocare security.